首页> 美国卫生研究院文献>Journal of the Boston Society of Medical Sciences >In situ characterization of antigenic and functional tissue factor expression in human tumors utilizing monoclonal antibodies and recombinant factor VIIa as probes.
【2h】

In situ characterization of antigenic and functional tissue factor expression in human tumors utilizing monoclonal antibodies and recombinant factor VIIa as probes.

机译:利用单克隆抗体和重组因子VIIa作为探针原位表征人类肿瘤中抗原和功能性组织因子的表达。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Tissue factor (TF), the primary initiator of blood coagulation in vivo, is expressed in vitro by a variety of cells. Previous efforts to localize TF in tissue and cells have been limited principally to the use of immunological techniques. In the present study, we describe a novel functional probe for TF expression, which can be utilized to localize functional TF in situ in human cells and tissues. This probe, a biotinylated phe-pro-arg-chloro-methyl-ketone-labeled rVIIa (FPR-ck-VIIa), interacts with TF via high-affinity binding sites. The binding of FPR-ck-VIIa, therefore, can be correlated with the ability of TF to activate clotting. In the described studies, TF antigen (TF:Ag) expression was examined immunohistochemically with various TF-specific monoclonal antibodies (MAbs) and was correlated with functional TF expression using our novel TF-binding probe (eg, FPR-ck-VIIa). Initial results indicate that TF:Ag expression correlates with the expression of functional TF (TF:VIIa), and the specificity of both types of probes was confirmed. Parallel antigenic and functional TF expression in situ was demonstrated in various human tumors. We believe this to be the first demonstration of functional TF in situ in human cells and tissues. We suggest that FPR-ck-VIIa should prove a useful reagent for studying the role of TF in the pathogenesis of clotting complications of human disease.
机译:组织因子(TF)是体内血液凝固的主要引发剂,在体外由多种细胞表达。先前在组织和细胞中定位TF的努力主要限于使用免疫学技术。在本研究中,我们描述了一种新型的TF表达功能探针,可用于在人类细胞和组织中原位定位功能性TF。该探针是一种生物素化的phe-pro-arg-氯-甲基-酮标记的rVIIa(FPR-ck-VIIa),通过高亲和力结合位点与TF相互作用。因此,FPR-ck-VIIa的结合可以与TF激活凝血的能力相关。在描述的研究中,使用各种TF特异性单克隆抗体(MAb)免疫组织化学检查了TF抗原(TF:Ag)的表达,并使用我们的新型TF结合探针(例如FPR-ck-VIIa)将其与功能性TF表达相关。初步结果表明,TF:Ag的表达与功能性TF(TF:VIIa)的表达相关,并且两种类型探针的特异性都得到了证实。在各种人类肿瘤中均证实了原位并行的抗原性和功能性TF表达。我们认为这是人类细胞和组织中功能性TF的首个证明。我们建议FPR-ck-VIIa应该被证明是用于研究TF在人类疾病凝血并发症发病机制中的作用的有用试剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号